Thymoproteasomes produce unique peptide motifs for positive selection of CD8+ T cells

Nature Communications

Volumn 6, Issue , 2015, Pages

  Sasaki, Katsuhiro ^a,d   Takada, Kensuke ^b   Ohte, Yuki ^a   Kondo, Hiroyuki ^b   Sorimachi, Hiroyuki ^c   Tanaka, Keiji ^c   Takahama, Yousuke ^b   Murata, Shigeo ^a  

^a UNIVERSITY OF TOKYO   (Japan)

^b UNIVERSITY OF TOKUSHIMA   (Japan)

^c TOKYO METROPOLITAN INSTITUTE OF MEDICAL SCIENCE   (Japan)

^d KYOTO UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

BETA CASEIN; ENOLASE; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; OVALBUMIN; PROTEASOME; T LYMPHOCYTE RECEPTOR; THYMOPROTEASOME; UNCLASSIFIED DRUG; HLA ANTIGEN CLASS 1; LYMPHOCYTE ANTIGEN RECEPTOR; PEPTIDE FRAGMENT; PROTEASOME SUBUNIT BETA5T, MOUSE;

ANTIGEN; ENZYME; GENE EXPRESSION; GERM CELL; LIGAND; PEPTIDE;

AMINO ACID SEQUENCE; ANIMAL CELL; ANTIGEN SPECIFICITY; ARTICLE; BINDING AFFINITY; CD8+ T LYMPHOCYTE; CONTROLLED STUDY; IN VITRO STUDY; LIGAND BINDING; LYMPHOCYTE FUNCTION; MOUSE; NONHUMAN; PROTEIN MOTIF; TRANSGENE; ANIMAL; CELL DIFFERENTIATION; CELL LINE; EPITHELIUM CELL; FLOW CYTOMETRY; IMMUNOLOGY; METABOLISM; THYMUS; WESTERN BLOTTING;

AMINO ACID MOTIFS; ANIMALS; BLOTTING, WESTERN; CD8-POSITIVE T-LYMPHOCYTES; CELL DIFFERENTIATION; CELL LINE; EPITHELIAL CELLS; FLOW CYTOMETRY; HISTOCOMPATIBILITY ANTIGENS CLASS I; IN VITRO TECHNIQUES; MICE; PEPTIDE FRAGMENTS; PROTEASOME ENDOPEPTIDASE COMPLEX; RECEPTORS, ANTIGEN, T-CELL; THYMUS GLAND;

EID: 84934975580     PISSN: None     EISSN: 20411723     Source Type: Journal    
DOI: 10.1038/ncomms8484     Document Type: Article

References (49)

1. Glickman, M., Ciechanover, A. The ubiquitin-proteasome proteolytic pathway: destruction for the sake of construction. Physiol. Rev. 82, 373-428 (2002).
2. Finley, D. Recognition and processing of ubiquitin-protein conjugates by the proteasome. Annu. Rev. Biochem. 78, 477-513 (2009).
3. Groll, M. et al. Structure of 20S proteasome from yeast at 2.4A resolution. Nature 386, 463-471 (1997).
4. Arendt, C. S., Hochstrasser, M. Identification of the yeast 20S proteasome catalytic centers and subunit interactions required for active-site formation. Proc. Natl Acad. Sci. USA 94, 7156-7161 (1997).
5. Unno, M. et al. The structure of the mammalian 20S proteasome at 2.75A resolution. Structure 10, 609-618 (2002).
6. Rock, K. L. et al. Inhibitors of the proteasome block the degradation of most cell proteins and the generation of peptides presented on MHC class I molecules. Cell 78, 761-771 (1994).
7. Kloetzel, P. M. Antigen processing by the proteasome. Nat. Rev. Mol. Cell Biol. 2, 179-187 (2001).
8. Groettrup, M., Kirk, C. J., Basler, M. Proteasomes in immune cells: more than peptide producers? Nat. Rev. Immunol. 10, 73-78 (2010).
9. Driscoll, J., Brown, M. G., Finley, D., Monaco, J. J. MHC-linked LMP gene products specifically alter peptidase activities of the proteasome. Nature 365, 262-264 (1993).
10. Gaczynska, M., Rock, K. L., Goldberg, A. L. Gamma-interferon and expression of MHC genes regulate peptide hydrolysis by proteasomes. Nature 365, 264-267 (1993).
11. Aki, M. et al. Interferon-gamma induces different subunit organizations and functional diversity of proteasomes. J. Biochem. 115, 257-269 (1994).
12. Groettrup, M. et al. A third interferon-gamma-induced subunit exchange in the 20S proteasome. Eur. J. Immunol. 26, 863-869 (1996).
13. Murata, S. et al. Regulation of CD8\+ T cell development by thymus-specific proteasomes. Science 316, 1349-1353 (2007).
14. Nitta, T. et al. Thymoproteasome shapes immunocompetent repertoire of CD8\+ T cells. Immunity 32, 29-40 (2010).
15. Ripen, A. M., Nitta, T., Murata, S., Tanaka, K., Takahama, Y. Ontogeny of thymic cortical epithelial cells expressing the thymoproteasome subunit b5t. Eur. J. Immunol. 41, 1278-1287 (2011).
16. Palmer, E., Naeher, D. Affinity threshold for thymic selection through a T-cell receptor-co-receptor zipper. Nat. Rev. Immunol. 9, 207-213 (2009).
17. Starr, T. K., Jameson, S. C., Hogquist, K. A. Positive and negative selection of T cells. Annu. Rev. Immunol. 21, 139-176 (2003).
18. Ziegler, A., Müller, C. Low-affinity peptides and T-cell selection. Trends Immunol. 30, 53-60 (2009).
19. Klein, L., Kyewski, B., Allen, P. M., Hogquist, K. A. Positive and negative selection of the T cell repertoire: what thymocytes see (and don't see). Nat. Rev. Immunol. 14, 377-391 (2014).
20. Toes, R. E. et al. Discrete cleavage motifs of constitutive and immunoproteasomes revealed by quantitative analysis of cleavage products. J. Exp. Med. 194, 1-12 (2001).
21. Rammensee, H. G., Falk, K., Rötzschke, O. Peptides naturally presented by MHC class I molecules. Annu. Rev. Immunol. 11, 213-244 (1993).
22. Matsumura, M., Fremont, D. H., Peterson, P. A., Wilson, I. A. Emerging principles for the recognition of peptide antigens by MHC class I molecules. Science 257, 927-934 (1992).
23. Harris, J. L., Alper, P. B., Li, J., Rechsteiner, M., Backes, B. J. Substrate specificity of the human proteasome. Chem. Biol. 8, 1131-1141 (2001).
24. Nazif, T., Bogyo, M. Global analysis of proteasomal substrate specificity using positional-scanning libraries of covalent inhibitors. Proc. Natl Acad. Sci. USA 98, 2967-2972 (2001).
25. Porgador, A., Yewdell, J. W., Deng, Y., Bennink, J. R., Germain, R. N. Localization, quantitation, and in situ detection of specific peptide-MHC class I complexes using a monoclonal antibody. Immunity 6, 715-726 (1997).
26. Jameson, S. C., Bevan, M. J. Dissection of major histocompatibility complex (MHC) and T cell receptor contact residues in a Kb-restricted ovalbumin peptide and an assessment of the predictive power of MHC-binding motifs. Eur. J. Immunol. 22, 2663-2667 (1992).
27. Hammer, G. E., Gonzalez, F., James, E., Nolla, H., Shastri, N. In the absence of aminopeptidase ERAAP, MHC class I molecules present many unstable and highly immunogenic peptides. Nat. Immunol. 8, 101-108 (2007).
28. Xing, Y., Jameson, S. C., Hogquist, K. A. Thymoproteasome subunit-b5T generates peptide-MHC complexes specialized for positive selection. Proc. Natl Acad. Sci. USA 110, 6979-6984 (2013).
29. Engelhard, V. Structure of peptides associated with MHC class I molecules. Curr. Opin. Immunol. 6, 13-23 (1994).
30. Hudrisier, D., Mazarguil, H., Laval, F., Oldstone, M. B. A., Gairin, J. E. Binding of viral antigens to major histocompatibility complex class I H-2Db molecules is controlled by dominant negative elements at peptide non-anchor residues: implications for peptide selection and presentation. J. Biol. Chem. 271, 17829-17836 (1996).
31. Daniels, M. A. et al. Thymic selection threshold defined by compartmentalization of Ras/MAPK signalling. Nature 444, 724-729 (2006).
32. Azzam, H. S. et al. CD5 expression is developmentally regulated by T cell receptor (TCR) signals and TCR avidity. J. Exp. Med. 188, 2301-2311 (1998).
33. Love, P. E., Lee, J., Shores, E. W. Critical relationship between TCR signaling potential and TCR affinity during thymocyte selection. J. Immunol. 165, 3080-3087 (2000).
34. Silver, M. L., Guo, H. C., Strominger, J. L., Wiley, D. C. Atomic structure of a human MHC molecule presenting an influenza virus peptide. Nature 360, 367-369 (1992).
35. Young, A. C., Zhang, W., Sacchettini, J. C., Nathenson, S. G. The threedimensional structure of H-2Db at 2.4A resolution: implications for antigendeterminant selection. Cell 76, 39-50 (1994).
36. Meijers, R. et al. Crystal structures of murine MHC Class I H-2 D(b) and K(b) molecules in complex with CTL epitopes from influenza A virus: implications for TCR repertoire selection and immunodominance. J. Mol. Biol. 345, 1099-1110 (2005).
37. Kelly, J. M. et al. Identification of conserved T cell receptor CDR3 residues contacting known exposed peptide side chains from a major histocompatibility complex class I-bound determinant. Eur. J. Immunol. 23, 3318-3326 (1993).
38. Jameson, S. C., Carbone, F. R., Bevan, M. J. Clone-specific T cell receptor antagonists of major histocompatibility complex class I-restricted cytotoxic T cells. J. Exp. Med. 177, 1541-1550 (1993).
39. Zhu, J. Y., Abate, M., Rice, P. W., Cole, C. N. The ability of simian virus 40 large T antigen to immortalize primary mouse embryo fibroblasts cosegregates with its ability to bind to p53. J. Virol. 65, 6872-6880 (1991).
40. Kitamura, T. New experimental approaches in retrovirus-mediated expression screening. Int. J. Hematol. 67, 351-359 (1998).
41. Cascio, P., Hilton, C., Kisselev, A. F., Rock, K. L., Goldberg, A. L. 26S proteasomes and immunoproteasomes produce mainly N-extended versions of an antigenic peptide. EMBO J. 20, 2357-2366 (2001).
42. Dick, L. R. et al. Proteolytic processing of ovalbumin and beta-galactosidase by the proteasome to a yield antigenic peptides. J. Immunol. 152, 3884-3894 (1994).
43. Akahane, T., Sahara, P., Yashiroda, H., Tanaka, K., Murata, S. Involvement of Bag6 and the TRC pathway in proteasome assembly. Nat. Commun. 4, 2234 (2013).
44. Rosette, C. et al. The impact of duration versus extent of TCR occupancy on T cell activation: a revision of the kinetic proofreading model. Immunity 15, 59-70 (2001).
45. Hogquist, K. A. et al. Identification of a naturally occurring ligand for thymic positive selection. Immunity 6, 389-399 (1997).
46. McGargill, M. A., Hogquist, K. A. Antigen-induced coreceptor downregulation on thymocytes is not a result of apoptosis. J. Immunol. 162, 1237-1245 (1999).
47. Van Kaer, L., Ashton-Rickardt, P. G., Ploegh, H. L., Tonegawa, S. TAP1 mutant mice are deficient in antigen presentation, surface class I molecules, and CD4-8\+ T cells. Cell 71, 1205-1214 (1992).
48. Hogquist, K. A. et al. T cell receptor antagonist peptides induce positive selection. Cell 76, 17-27 (1994).
49. Morse, III H. C., Shen, F. W., Hämmerling, U. Genetic nomenclature for loci controlling mouse lymphocyte antigens. Immunogenetics 25, 71-78 (1987).